Cargando…

The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapy

BACKGROUND: Programmed death-ligand 1 (PD-L1) expression has been shown to be prognostic in many cancer types and used in consideration of checkpoint inhibitor immunotherapy. However, there are very limited and conflicting data on the prognostic impact of PD-L1 in patients with anal squamous cell ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Angela MY., Roldan Urgoiti, Gloria, Jiang, Will, Lee, Sandra, Kornaga, Elizabeth, Mathen, Peter, Yeung, Rosanna, Enwere, Emeka K., Box, Alan, Konno, Mie, Koebel, Martin, Joseph, Kurian, Doll, Corinne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585228/ https://www.ncbi.nlm.nih.gov/pubmed/36276142 http://dx.doi.org/10.3389/fonc.2022.1000263

Ejemplares similares

Intensity-Modulated Radiotherapy (IMRT) vs Helical Tomotherapy (HT) in Concurrent Chemoradiotherapy (CRT) for Patients with Anal Canal Carcinoma (ACC): an analysis of dose distribution and toxicities
por: Yeung, Rosanna, et al.
Publicado: (2015)

The Prognostic Value of HPV Status and p16 Expression in Patients with Carcinoma of the Anal Canal
por: Roldán Urgoiti, Gloria B., et al.
Publicado: (2014)

Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study
por: Koulis, Theodora A., et al.
Publicado: (2017)

Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer
por: Chanda, Ayan, et al.
Publicado: (2017)

Impact of tumoral carbonic anhydrase IX and Ki-67 expression on survival in oral squamous cell carcinoma patients
por: Brockton, Nigel T., et al.
Publicado: (2017)

Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy
por: Charnley, N, et al.
Publicado: (2005)

Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy
por: Jones, Michael, et al.
Publicado: (2015)

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option
por: Meulendijks, D, et al.
Publicado: (2014)

Sarcopenia Is Associated With Hematologic Toxicity During Chemoradiotherapy in Patients With Anal Carcinoma
por: Martin, Daniel, et al.
Publicado: (2020)

IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma
por: De Felice, Francesca, et al.
Publicado: (2023)

Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer
por: Martin, Daniel, et al.
Publicado: (2017)

Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer
por: Feng, Xiaolan, et al.
Publicado: (2015)

FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy
por: Day, F L, et al.
Publicado: (2011)

Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience
por: Kim, Kyung Hwan, et al.
Publicado: (2013)

Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC)
por: Fish, R., et al.
Publicado: (2018)

PD-1/PD-L1 expression in anal squamous intraepithelial lesions
por: Bucau, Margot, et al.
Publicado: (2020)

Alternative chemoradiotherapy in anal carcinoma patients with mutations in thymidylate synthase and dihydropyrimidine dehydrogenase genes
por: Saif, MW, et al.
Publicado: (2021)

Low Ki67/high ATM protein expression in malignant tumors predicts favorable prognosis in a retrospective study of early stage hormone receptor positive breast cancer
por: Feng, Xiaolan, et al.
Publicado: (2016)

Change in PD-L1 and CD8 Expression after Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
por: Chen, Wei-Chung, et al.
Publicado: (2022)

High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy
por: Fraunholz, Ingeborg, et al.
Publicado: (2012)

Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma
por: Bluemke, Emma, et al.
Publicado: (2020)

The Role of Haematological Parameters in Predicting the Response To Radical Chemoradiotherapy in Patients with Anal Squamous Cell Cancer
por: Stojanovic-Rundic, Suzana, et al.
Publicado: (2021)

High-grade neuroendocrine small-cell carcinoma of the anal canal: Long-term remission with chemoradiotherapy
por: Hajjar, Roy, et al.
Publicado: (2021)

High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy
por: Mitra, Devarati, et al.
Publicado: (2019)

C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy
por: Martin, Daniel, et al.
Publicado: (2019)

Adjuvant chemoradiotherapy does not improve outcomes in patients with fistula-associated anal adenocarcinoma undergoing abdominoperineal resection
por: Wang, Min, et al.
Publicado: (2022)

Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation
por: Wang, Yaqi, et al.
Publicado: (2022)

PD-1/PD-L1 Correlates With the Efficacy of the Treatment of Concurrent Chemoradiotherapy in Cervical Cancer
por: Zhang, Hanqun, et al.
Publicado: (2022)

Theatre and laboratory workers’ awareness of and safety practices against hepatitis B and C infection in a suburban university teaching hospital in Nigeria
por: Okwara, Emmanuel Chidiebere, et al.
Publicado: (2012)

Photobiomodulation as a treatment for dermatitis caused by chemoradiotherapy for squamous cell anal carcinoma: case report and literature review
por: Hottz, Fabiana, et al.
Publicado: (2022)

Feasibility and Implementation of an Oncology Rehabilitation Triage Clinic: Assessing Rehabilitation, Exercise Need, and Triage Pathways within the Alberta Cancer Exercise–Neuro-Oncology Study
por: Capozzi, Lauren C., et al.
Publicado: (2023)

The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer
por: Kochhar, Rohit, et al.
Publicado: (2016)

Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy
por: Adusumilli, Pratik, et al.
Publicado: (2022)

High-resolution anoscopy predictive modeling of anal canal cancer response after definitive chemoradiotherapy in COVID19 era
por: De Felice, Francesca, et al.
Publicado: (2022)

A pilot study investigating the role of (18)F‐FDG‐PET in the early identification of chemoradiotherapy response in anal cancer
por: Smith, Drew, et al.
Publicado: (2022)

Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
por: Wessely, Anja, et al.
Publicado: (2020)

Pencil Beam Scanning (PBS) Intensity-Modulated Proton Therapy (IMPT) Chemoradiotherapy for Anal Canal Cancer—Single Institution Experience
por: Vítek, Pavel, et al.
Publicado: (2021)

Role of the TWEAK-Fn14-cIAP1-NF-κB Signaling Axis in the Regulation of Myogenesis and Muscle Homeostasis
por: Enwere, Emeka K., et al.
Publicado: (2014)

Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells
por: Arjumand, Wani, et al.
Publicado: (2016)

PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus
por: Fassan, Matteo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8ot9bgs9ic8gn6ii6fodpugo9s